Ozempic (semaglutide) and other GLP-1 receptor agonists have become widely used medications for type 2 diabetes and weight loss. While many patients take these drugs without experiencing serious side effects, growing research and an increasing number of lawsuits have raised concerns about a potential link to a serious eye condition known as non-arteritic anterior ischemic optic neuropathy, or NAION. 

NAION is a condition that can cause sudden vision loss, often without warning. In many cases, the damage may be permanent. As a result, patients and doctors are now asking an important question: can Ozempic or other GLP-1 medications lead to permanent blindness? 

Our law firm, Hissey Mulderig & Friend, is actively investigating claims involving Ozempic or other GLP-1 medications and vision loss caused by NAION. If you or a loved one experienced sudden vision after taking Ozempic, Wegovy (semaglutide), Mounjaro (tirzepatide), or similar medications, you may be eligible to file a lawsuit and receive compensation.  

Find out whether you qualify or start your claim today by the lawyers at Hissey Mulderig & Friend toll-free at 1-866-806-8117. You can also reach us by filling out our free claim submission form, located on the right side of this page. 

What Is NAION?

Non-arteritic anterior ischemic optic neuropathy, also known as NAION, is a condition caused by reduced blood flow to the optic nerve. The optic nerve is responsible for transmitting visual signals from the eye to the brain. When that blood supply is disrupted, the nerve can become damaged. 

NAION is often described as an “eye stroke” because it involves a sudden loss of blood flow. Unlike some eye conditions that develop gradually, NAION typically occurs quickly and without pain. Many patients first notice symptoms when they wake up and realize their vision has changed. 

Common symptoms may include: 

• Sudden vision loss in one eye 
• Blurred or dim vision 
• Loss of peripheral vision 
• Dark or shadowed areas in the field of vision 
• Reduced color perception 

In many cases, the vision loss caused by NAION does not improve over time. 

Can Ozempic Cause Permanent Blindness?

The short answer is that NAION itself can cause permanent vision loss, and researchers are actively studying whether Ozempic and other GLP-1 medications may increase the risk of developing this condition. 

A widely discussed study published in JAMA Ophthalmology found that patients taking semaglutide may have a higher risk of being diagnosed with NAION compared to other patients. This study drew national attention and helped bring the issue into both the medical and legal spotlight. 

More recent research has taken a broader look at millions of patients across multiple healthcare databases. Some findings suggest an increased risk of NAION during periods when patients are actively taking semaglutide, while other comparisons have been less conclusive. Researchers have emphasized that additional study is needed to fully understand the relationship. 

However, one point is not in dispute. When NAION occurs, the resulting damage to the optic nerve is often permanent. There is currently no proven treatment that can restore lost vision once significant damage has occurred. 

Because of this, even a potential increase in risk is being taken seriously. 

Why Researchers Are Concerned About GLP-1 Drugs

Scientists have not identified a single confirmed mechanism linking GLP-1 medications to NAION, but there are several reasons why this connection is being investigated. 

NAION is a condition related to blood flow. It occurs when circulation to the optic nerve is reduced. Researchers are examining whether GLP-1 medications may influence vascular function, blood pressure, or other factors that could affect how blood reaches the optic nerve. 

This concern becomes more significant when considering the population that typically uses these medications. Many GLP-1 patients already have underlying conditions such as diabetes, high blood pressure, or cardiovascular disease. These conditions are also known risk factors for NAION. 

This overlap has led researchers to question whether GLP-1 medications could increase the likelihood of NAION in patients who are already vulnerable. 

Are Other GLP-1 Drugs Involved?

Ozempic (semaglutide) has been the primary focus of most NAION research so far. Wegovy (semaglutide) contains the same active ingredient and is often discussed alongside Ozempic. 

Other GLP-1 medications include: 

• Mounjaro (tirzepatide) 
• Saxenda (liraglutide) 
• Trulicity (dulaglutide) 

While these drugs have been mentioned in lawsuits, the strongest scientific data currently relates to semaglutide. Research involving other GLP-1 medications is still developing. 

Because of this, patients who experienced vision loss after taking any GLP-1 drug may still want to explore their legal options, even as the science continues to evolve. 

Who May Be at Higher Risk?

Certain individuals may have a higher risk of developing NAION, regardless of medication use. These risk factors may include: 

• Diabetes 
• High blood pressure 
• Cardiovascular disease 
• Sleep apnea 
• Age over 50 

Because many patients taking GLP-1 medications already have these conditions, the potential for increased risk has raised additional concern. 

What Are Lawsuits Alleging?

Lawsuits involving Ozempic and other GLP-1 drugs generally allege that manufacturers failed to adequately warn patients and healthcare providers about the potential risk of vision loss. 

Plaintiffs argue that if clearer warnings had been provided, they may have made different decisions about their treatment or monitored symptoms more closely. 

These cases are now being consolidated into multidistrict litigation, where courts will evaluate shared evidence and legal arguments. 

What Should You Do If You Experience Vision Loss?

If you notice sudden vision changes while taking a GLP-1 medication, taking immediate action is important. 

You should: 

• Seek urgent medical attention from an eye specialist 
• Request copies of your medical records and diagnosis 
• Document when your symptoms began 
• Keep records of your prescription history 
• Speak with an attorney about your legal options 

Prompt evaluation can help confirm whether NAION or another serious condition is involved. 

The Long-Term Impact of NAION

Vision loss from NAION can affect nearly every part of daily life. Patients may experience difficulty driving, reading, working, or performing routine tasks. 

In many cases, these changes are permanent. Some individuals may also experience emotional and financial challenges as a result of their condition. 

Because of these long-term effects, legal claims involving NAION often focus not only on medical expenses, but also on loss of independence and quality of life. 

Speak With an Attorney About Your Legal Options

The question of whether Ozempic can cause permanent blindness continues to be studied, but what is already clear is that NAION can lead to lasting and life-changing vision loss. As research continues to examine the connection between GLP-1 medications and optic nerve damage, more patients are coming forward with similar experiences. 

If you or a loved one developed NAION or sudden vision loss after taking Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or another GLP-1 drug, you may be eligible to file a lawsuit and receive compensation. 

The law firm of Hissey Mulderig & Friend is actively investigating Ozempic vision loss claims. Our attorneys work on a strict contingency basis, meaning you will never pay legal fees or other costs related to filing a lawsuit unless we successfully recover damages in your case. 

Talk with a lawyer to find out whether you qualify to take legal action or start the process of filing your claim today by contacting Hissey Mulderig & Friend toll-free at 1-866-806-8117. You can also get in touch by filling out our free Ozempic claim submission form, which is located at the top of this page.